Dokumente
Suchschritt : FT=glucosamine AND FT=osteoarthritis
» Fenster schließen »

2/11 von 414 DIMDI: MEDLINE (ME60) © NLM

ND: | ME17257091
PMID: | 17257091
CED: | 20070129
DCO: | 20070220
Autoren: | Herrero-Beaumont G; Rovati LC; Castañeda S; Alvarez-Soria MA; Largo R
Titel: | The reverse glucosamine sulfate pathway: application in knee osteoarthritis.
Quelle: | Expert opinion on pharmacotherapy; VOL: 8 (2); p. 215-25 /200702/
PM: | Print
SU: | IM
Sprache: | English
CY: | England
JID: | 100897346
ISSN: | 1744-7666
Institution: | Rheumatology Department, Joint and Bone Research Laboratory, Fundación Jiménez Díaz--Capio, Autonomous University of Madrid, Avenida Reyes Católicos 2, 28040 Madrid, Spain. gherrero@fjd.es
DT: | Journal Article; Review
RN: | 90
Schlagwörter
CT: | CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSAMINE/adverse effects; GLUCOSAMINE/metabolism; GLUCOSAMINE/pharmacology; GLUCOSAMINE/*therapeutic use; HUMANS; OSTEOARTHRITIS, KNEE/*drug therapy; PRODUCT SURVEILLANCE, POSTMARKETING
CTG: | KLINISCHE STUDIEN; DOSIS-WIRKUNGSBEZIEHUNG, ARZNEIMITTEL-; GLUCOSAMIN/unerwünschte Nebenwirkungen; GLUCOSAMIN/Stoffwechsel; GLUCOSAMIN/Pharmakologie; GLUCOSAMIN/*therapeutische Anwendung; MENSCH; OSTEOARTHROSE, KNIE/*Arzneimitteltherapie; PRODUKTÜBERWACHUNG NACH MARKTEINFÜHRUNG
TE: | Glucosamine/3416-24-8
CR: | 3416-24-8
AB: | Glucosamine is a natural amino sugar and a normal constituent of glycosaminoglycans in the cartilage matrix and synovial fluid of joints. Crystalline glucosamine sulfate salt has been approved as a medicinal product for the treatment of osteoarthritis in several European countries. Nevertheless, although it has been prescribed for more than 10 years, it is only due to the research in the last 5 years that the scientific basis underlying its beneficial effects are starting to be clarified. In randomised, double-blind, placebo-controlled trials, this compound clinically controls pain and produces beneficial effects in patients with knee osteoarthritis, possibly delaying the appearance of long-term structural changes in the joint (i.e., it has a structure-modifying effect). Furthermore, it has an excellent toxicity profile. Despite the different lines of investigation that have been followed, the mechanism of action of glucosamine sulfate still remains to be clearly defined. However, the activity of glucosamine sulfate has recently been related to its capacity to downregulate the catabolic effects of pro-inflammatory molecules, such as IL-1, which are present in osteoarthritic cartilage.

» Volltext »
» Fenster schließen »